- Home
- BODI vs ESLA Comparison
BODI vs ESLA Comparison
Compare BODI & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BODI | ESLA |
|---|---|---|
| Founded | 1998 | 2021 |
| Country | United States | United States |
| Employees | 270 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.4M | 69.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BODI | ESLA |
|---|---|---|
| Price | $10.18 | $1.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $15.00 | $8.00 |
| AVG Volume (30 Days) | ★ 66.3K | 28.4K |
| Earning Date | 05-07-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20.48 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.53 | $0.78 |
| 52 Week High | $16.87 | $3.15 |
Technical Indicators
Market Signals| Indicator | BODI | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 39.53 | 42.52 |
| Support Level | $9.54 | $0.98 |
| Resistance Level | $11.11 | $1.31 |
| Average True Range (ATR) | 0.92 | 0.09 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 33.91 | 50.00 |
Price Performance
Historical ComparisonAbout BODI The Beachbody Company Inc.
The Beachbody Co Inc is a fitness and nutrition company providing fitness, nutrition, and stress-reducing programs to its customers. a results-oriented company at the intersection of wellness, technology, and media. The company developed one of the original fitness digital streaming platforms with an extensive library of content containing streaming programs and streaming videos. Company products include Digital Subscriptions, Nutritional Products, and Connected Fitness Products, where the majority of revenue is from Digital Subscriptions. The Company has one operating and reporting segment. Geographically operates in the USA and the rest of the world, with maximum revenue from the United States.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.